Real-World Comparison of Dual Checkpoint Blockade and Immunotherapy Plus TKIs in Metastatic RCC.

Ohba K, Oki M, Matsuda T, Miyata H, Kikuchi H, Inoue T, Shin T, Sekine Y, Narita S, Naito S, Tsuchiya N, Naito H, Sugimoto M, Numakura K, Kobayashi S, Ueda K, Igawa T, Mitsunari K, Matsuo T, Imamura R

Open source

DOI
10.1002/cam4.72265
Published
2026 Sep
Container
Cancer medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cam4.72265,
  title = {Real-World Comparison of Dual Checkpoint Blockade and Immunotherapy Plus TKIs in Metastatic RCC.},
  author = {Ohba K and Oki M and Matsuda T and Miyata H and Kikuchi H and Inoue T and Shin T and Sekine Y and Narita S and Naito S and Tsuchiya N and Naito H and Sugimoto M and Numakura K and Kobayashi S and Ueda K and Igawa T and Mitsunari K and Matsuo T and Imamura R},
  year = {2026},
  journal = {Cancer medicine},
  doi = {10.1002/cam4.72265},
  url = {https://doi.org/10.1002/cam4.72265}
}

RIS

TY  - JOUR
TI  - Real-World Comparison of Dual Checkpoint Blockade and Immunotherapy Plus TKIs in Metastatic RCC.
AU  - Ohba K
AU  - Oki M
AU  - Matsuda T
AU  - Miyata H
AU  - Kikuchi H
AU  - Inoue T
AU  - Shin T
AU  - Sekine Y
AU  - Narita S
AU  - Naito S
AU  - Tsuchiya N
AU  - Naito H
AU  - Sugimoto M
AU  - Numakura K
AU  - Kobayashi S
AU  - Ueda K
AU  - Igawa T
AU  - Mitsunari K
AU  - Matsuo T
AU  - Imamura R
PY  - 2026
JO  - Cancer medicine
DO  - 10.1002/cam4.72265
UR  - https://doi.org/10.1002/cam4.72265
ER  - 

APA

K, O., M, O., T, M., H, M., H, K., T, I., T, S., Y, S., S, N., S, N., N, T., H, N., M, S., K, N., S, K., K, U., T, I., K, M., T, M., & R, I. (2026). Real-World Comparison of Dual Checkpoint Blockade and Immunotherapy Plus TKIs in Metastatic RCC.. Cancer medicine. https://doi.org/10.1002/cam4.72265

Source records